Atlas Trials

HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT02437110 · COMPLETED

Trial details

NCT number
NCT02437110
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Amyotrophic Lateral Sclerosis
Start date
2019-04-01
Primary completion
2022-11-17
Enrollment
122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.